Your browser doesn't support javascript.
The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A.
Wu, Shang-Chuen; Arthur, Connie M; Wang, Jianmei; Verkerke, Hans; Josephson, Cassandra D; Kalman, Daniel; Roback, John D; Cummings, Richard D; Stowell, Sean R.
  • Wu SC; Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Arthur CM; Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA; and.
  • Wang J; Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA; and.
  • Verkerke H; Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA; and.
  • Josephson CD; Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA; and.
  • Kalman D; Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA; and.
  • Roback JD; Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, GA; and.
  • Cummings RD; Harvard Glycomics Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Stowell SR; Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Blood Adv ; 5(5): 1305-1309, 2021 03 09.
Article in English | MEDLINE | ID: covidwho-1388718

Full text: Available Collection: International databases Database: MEDLINE Main subject: Oligosaccharides / ABO Blood-Group System / Alveolar Epithelial Cells / Spike Glycoprotein, Coronavirus Type of study: Randomized controlled trials Limits: Humans Language: English Journal: Blood Adv Year: 2021 Document Type: Article Affiliation country: BLOODADVANCES.2020003259

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Oligosaccharides / ABO Blood-Group System / Alveolar Epithelial Cells / Spike Glycoprotein, Coronavirus Type of study: Randomized controlled trials Limits: Humans Language: English Journal: Blood Adv Year: 2021 Document Type: Article Affiliation country: BLOODADVANCES.2020003259